MedTrace Logo

Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases

NCT05337332 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-04-20

No results posted yet for this study

Summary

Suprachoroidal injection is a safe way for intraocular drug delivery. It was used to treat various retinal conditions.

Conditions

  • Central Serous Chorioretinopathy
  • Irvine-Gass Syndrome
  • Pars Planitis
  • Cystoid Macular Edema

Interventions

DRUG

Triamcinolone Acetonide

Suprachoroidal injection of triamcinolone acetonide

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • Ahmed A Abdelshafy, MD · Benha University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-14
Primary Completion
2023-05-30
Completion
2023-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05337332 on ClinicalTrials.gov